-+ 0.00%
-+ 0.00%
-+ 0.00%

CERVOMED ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2 STUDY OF NEFLAMAPIMOD FOR NONFLUENT VARIANT PRIMARY PROGRESSIVE APHASIA, A TYPE OF FRONTOTEMPORAL DEMENTIA

Reuters·07/09/2026 11:30:01

Please log in to view news